Zoledronic acid and denosumab are associated with similar fracture incidence and mortality in patients with type 2 diabetes: a population-based cohort study
Our findings suggest comparability of Zoledronic Acid and Denosumab in managing osteoporotic fractures and mortality among patients with type 2 diabetes.
Authors
- Vanessa Rouach (ORCID: https://orcid.org/0000-0003-4641-1465)
- Yona Greenman (ORCID: https://orcid.org/0000-0003-4923-488X)
- Inbal Goldshtein (ORCID: https://orcid.org/0000-0002-5317-2848)
- Hilary Gortler
- Gabriel Chodick (ORCID: https://orcid.org/0000-0002-5189-8995)
Institutions
- Tel Aviv University (IL)
- Tel Aviv Sourasky Medical Center (IL)
- Maccabi Institute for Health Services Research (IL)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2025-08-04
- DOI
- https://doi.org/10.3389/fendo.2025.1590472
- Citations
- 3
- Primary Topic
- Bone health and osteoporosis research
- Type
- article
- Field-Weighted Citation Impact
- 5.16